ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01369862
Recruitment Status : Completed
First Posted : June 9, 2011
Last Update Posted : January 10, 2014
Sponsor:
Information provided by:
AVIR Green Hills Biotechnology AG

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2011
  Actual Study Completion Date : August 2011